ES8105394A1 - Procedimiento para la preparacion de cepas mutantes para va-cunacion - Google Patents

Procedimiento para la preparacion de cepas mutantes para va-cunacion

Info

Publication number
ES8105394A1
ES8105394A1 ES495046A ES495046A ES8105394A1 ES 8105394 A1 ES8105394 A1 ES 8105394A1 ES 495046 A ES495046 A ES 495046A ES 495046 A ES495046 A ES 495046A ES 8105394 A1 ES8105394 A1 ES 8105394A1
Authority
ES
Spain
Prior art keywords
preparation
culture
antibiotic
salmonella abortus
abortus ovis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES495046A
Other languages
English (en)
Spanish (es)
Other versions
ES495046A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
Original Assignee
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Recherche Agronomique INRA filed Critical Institut National de la Recherche Agronomique INRA
Publication of ES495046A0 publication Critical patent/ES495046A0/es
Publication of ES8105394A1 publication Critical patent/ES8105394A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/824—Bacterial vaccine for ovine species, e.g. sheep
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/879—Salmonella

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES495046A 1979-08-29 1980-08-29 Procedimiento para la preparacion de cepas mutantes para va-cunacion Expired ES8105394A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7921685A FR2464300B1 (fr) 1979-08-29 1979-08-29 Preparation de souches salmonella abortus ovis et compositions de vaccins les contenant

Publications (2)

Publication Number Publication Date
ES495046A0 ES495046A0 (es) 1981-06-16
ES8105394A1 true ES8105394A1 (es) 1981-06-16

Family

ID=9229189

Family Applications (1)

Application Number Title Priority Date Filing Date
ES495046A Expired ES8105394A1 (es) 1979-08-29 1980-08-29 Procedimiento para la preparacion de cepas mutantes para va-cunacion

Country Status (7)

Country Link
US (1) US4350684A (enExample)
ES (1) ES8105394A1 (enExample)
FR (1) FR2464300B1 (enExample)
GB (1) GB2062675B (enExample)
GR (1) GR72542B (enExample)
IT (1) IT1148719B (enExample)
NZ (1) NZ194809A (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU554781B2 (en) * 1982-12-30 1986-09-04 Vsesojuzny Gosudarstvenny Nauchno-Kontrolny Institut Veterinarnykh Preparatov And Vsesojuzny Nauchno- Issledovatelsky Veterinarny Institut Ptitsvodstva Live salmonella typhi-murium vaccine
IE940698L (en) * 1984-04-05 1985-10-05 Univ Missouri Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant
FR2569721B1 (fr) * 1984-09-06 1986-09-19 Agronomique Inst Nat Rech Souches mutantes de listeria monocytogenes, leur procede d'obtention et vaccins vivants attenues en contenant
US4764370A (en) * 1984-09-12 1988-08-16 Scripps Clinic And Research Foundation Vaccine utilizing an avirulent strain of Salmonella typhimurium
FR2578424B1 (fr) * 1985-03-08 1988-07-08 Agronomique Inst Nat Rech Souches mutantes, vaccinantes de bacteries, leur procede d'obtention, et preparations vaccinales les contenant
US20050180985A9 (en) * 2001-10-04 2005-08-18 Vladoianu Ion R. Live attenuated salmonella strains for producing monovalent or multivalent vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2315912A1 (de) * 1973-03-30 1974-10-10 Univ Schiller Jena Verfahren zur herstellung von oralimpfstoffen gegen enterobacteriaceae-erkrankungen

Also Published As

Publication number Publication date
IT1148719B (it) 1986-12-03
NZ194809A (en) 1983-06-17
GR72542B (enExample) 1983-11-17
ES495046A0 (es) 1981-06-16
GB2062675B (en) 1984-03-28
IT8024371A0 (it) 1980-08-29
GB2062675A (en) 1981-05-28
US4350684A (en) 1982-09-21
FR2464300A1 (fr) 1981-03-06
FR2464300B1 (fr) 1983-08-05

Similar Documents

Publication Publication Date Title
Elberg et al. IMMUNIZATION AGAINST BRUCELLA INFECTION VI. Brucella melitensis: Immunity Conferred on Goats by a Nondependent Mutant from a Streptomycin-Dependent Mutant Strain of
Theiler et al. The use of yellow fever virus modified by in vitro cultivation for human immunization
EP0672116A4 (en) DELETION MUTANTS AS A VACCINE AGAINST CHOLERA.
ES8505719A1 (es) Procedimiento de preparar mutantes de delecion vivos y metodo de preparar vacunas
CA2094515A1 (en) Bacterial Attenuation Method and Vaccine
IE781639L (en) Fowl cholera vaccine
SE9003198D0 (sv) Fish vaccine comprising a virulent, invasive bacterium
GB1593567A (en) Live newcastle disease virus vaccine
EP1323428A3 (en) Avirulent Salmonella typhi microbes and uses thereof
ES8105394A1 (es) Procedimiento para la preparacion de cepas mutantes para va-cunacion
JPS5527178A (en) Live influenza virus vaccine
Takai et al. Effect of growth temperature on maintenance of virulent Rhodococcus equi
Gaines et al. STUDIES ON INFECTION AND IMMUNITY IN EXPERIMENTAL TYPHOID FEVER: III. EFFECT OF PROPHYLACTIC IMMUNIZATION
Potel et al. Listeria monocytogenes-vaccine: production and control
JPS55148094A (en) Preparation of l-glutamine by fermentation
Schütze Studies on B. pestis antigens as prophylactic agents
Baturo et al. Antigenic scheme for the Hafniae
JPS5696692A (en) Novel influenza virus strain and influenza virus vaccine containing same
SU1839960A1 (ru) Штамм бактерий francisella tularensis для приготовления живой вакцины против туляремийной инфекции
Dulaney Microbic dissociation of B. coli-communis
Vonka et al. Serological properties of antigenically different derivatives of LSc 2 ab poliovirus
SU549470A1 (ru) Способ получени живой брюшнотифозной вакцины
Hageage Jr et al. In vitro plaque formation by several oral diphtheroids implicated in periodontal disease
Baron et al. Immunization studies with living vaccine of Salmonella typhimurium.
Damjanovic Freeze-drying of live oral streptomycin dependent mutant Shigella vaccines: survival of streptomycin-dependent Shigella sonnei after freeze-drying